Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.780
+0.230 (6.48%)
Nov 19, 2025, 3:03 PM EST - Market open
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $669.2 million as of November 19, 2025. Its market cap has increased by 30.44% in one year.
Market Cap
669.20M
Enterprise Value
533.33M
1-Year Change
30.44%
Ranking
Category
Stock Price
$3.78
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $669.20M, a decrease of -58.88%. That is a compound annual growth rate of -25.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 628.49M | 68.69% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |